These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38720951)

  • 41. Validity and Performance of Blood Biomarkers for Alzheimer Disease to Predict Dementia Risk in a Large Clinic-Based Cohort.
    Planche V; Bouteloup V; Pellegrin I; Mangin JF; Dubois B; Ousset PJ; Pasquier F; Blanc F; Paquet C; Hanon O; Bennys K; Ceccaldi M; Annweiler C; Krolak-Salmon P; Godefroy O; Wallon D; Sauvee M; Boutoleau-Bretonnière C; Bourdel-Marchasson I; Jalenques I; Chene G; Dufouil C;
    Neurology; 2023 Jan; 100(5):e473-e484. PubMed ID: 36261295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
    Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
    JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma-derived biomarkers of Alzheimer's disease and neuropsychiatric symptoms: A community-based study.
    Krell-Roesch J; Zaniletti I; Syrjanen JA; Kremers WK; Algeciras-Schimnich A; Dage JL; van Harten AC; Fields JA; Knopman DS; Jack CR; Petersen RC; Vassilaki M; Geda YE
    Alzheimers Dement (Amst); 2023; 15(3):e12461. PubMed ID: 37529120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.
    Dickerson BC; Stoub TR; Shah RC; Sperling RA; Killiany RJ; Albert MS; Hyman BT; Blacker D; Detoledo-Morrell L
    Neurology; 2011 Apr; 76(16):1395-402. PubMed ID: 21490323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests.
    Barthélemy NR; Salvadó G; Schindler SE; He Y; Janelidze S; Collij LE; Saef B; Henson RL; Chen CD; Gordon BA; Li Y; La Joie R; Benzinger TLS; Morris JC; Mattsson-Carlgren N; Palmqvist S; Ossenkoppele R; Rabinovici GD; Stomrud E; Bateman RJ; Hansson O
    Nat Med; 2024 Apr; 30(4):1085-1095. PubMed ID: 38382645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231.
    Bayoumy S; Verberk IMW; den Dulk B; Hussainali Z; Zwan M; van der Flier WM; Ashton NJ; Zetterberg H; Blennow K; Vanbrabant J; Stoops E; Vanmechelen E; Dage JL; Teunissen CE
    Alzheimers Res Ther; 2021 Dec; 13(1):198. PubMed ID: 34863295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes.
    Pase MP; Beiser AS; Himali JJ; Satizabal CL; Aparicio HJ; DeCarli C; Chêne G; Dufouil C; Seshadri S
    JAMA Neurol; 2019 May; 76(5):598-606. PubMed ID: 30830207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease.
    Janelidze S; Stomrud E; Smith R; Palmqvist S; Mattsson N; Airey DC; Proctor NK; Chai X; Shcherbinin S; Sims JR; Triana-Baltzer G; Theunis C; Slemmon R; Mercken M; Kolb H; Dage JL; Hansson O
    Nat Commun; 2020 Apr; 11(1):1683. PubMed ID: 32246036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropathologic Correlates of Human Cortical Proteins in Alzheimer Disease and Related Dementias.
    Yu L; Boyle PA; Wingo AP; Yang J; Wang T; Buchman AS; Wingo TS; Seyfried NT; Levey AI; De Jager PL; Schneider JA; Bennett DA
    Neurology; 2022 Mar; 98(10):e1031-e1039. PubMed ID: 34937778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma Phosphorylated Tau at Threonine 181 and Neuropsychiatric Symptoms in Preclinical and Prodromal Alzheimer Disease.
    Ghahremani M; Wang M; Chen HY; Zetterberg H; Smith E; Ismail Z;
    Neurology; 2023 Feb; 100(7):e683-e693. PubMed ID: 36323521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Brain Gray Matter Volume Mediated the Correlation Between Plasma P-Tau and Cognitive Function of Early Alzheimer's Disease in China: A Cross-Sectional Observational Study.
    Wan K; Yin W; Tang Y; Zhu W; Wang Z; Zhou X; Zhang W; Zhang C; Yu X; Zhao W; Li C; Zhu X; Sun Z
    J Alzheimers Dis; 2023; 92(1):81-93. PubMed ID: 36710682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. P-tau217 in Alzheimer's disease.
    Telser J; Risch L; Saely CH; Grossmann K; Werner P
    Clin Chim Acta; 2022 Jun; 531():100-111. PubMed ID: 35341762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum.
    Donovan NJ; Wadsworth LP; Lorius N; Locascio JJ; Rentz DM; Johnson KA; Sperling RA; Marshall GA;
    Am J Geriatr Psychiatry; 2014 Nov; 22(11):1168-79. PubMed ID: 23890751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.
    Ashton NJ; Pascoal TA; Karikari TK; Benedet AL; Lantero-Rodriguez J; Brinkmalm G; Snellman A; Schöll M; Troakes C; Hye A; Gauthier S; Vanmechelen E; Zetterberg H; Rosa-Neto P; Blennow K
    Acta Neuropathol; 2021 May; 141(5):709-724. PubMed ID: 33585983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology.
    Kac PR; González-Ortiz F; Emeršič A; Dulewicz M; Koutarapu S; Turton M; An Y; Smirnov D; Kulczyńska-Przybik A; Varma V; Ashton NJ; Montoliu-Gaya L; Camporesi E; Winkel I; Paradowski B; Moghekar A; Troncoso JC; Brinkmalm G; Resnick SM; Mroczko B; Kvartsberg H; Kramberger MG; Hanrieder J; Čučnik S; Harrison P; Zetterberg H; Lewczuk P; Thambisetty M; Rot U; Galasko D; Blennow K; Karikari TK
    medRxiv; 2023 Dec; ():. PubMed ID: 38168323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals.
    Ferreira PCL; Therriault J; Tissot C; Ferrari-Souza JP; Benedet AL; Povala G; Bellaver B; Leffa DT; Brum WS; Lussier FZ; Bezgin G; Servaes S; Vermeiren M; Macedo AC; Cabrera A; Stevenson J; Triana-Baltzer G; Kolb H; Rahmouni N; Klunk WE; Lopez OL; Villemagne VL; Cohen A; Tudorascu DL; Zimmer ER; Karikari TK; Ashton NJ; Zetterberg H; Blennow K; Gauthier S; Rosa-Neto P; Pascoal TA
    Alzheimers Dement; 2023 Oct; 19(10):4463-4474. PubMed ID: 37534889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease.
    Wang L; Benzinger TL; Hassenstab J; Blazey T; Owen C; Liu J; Fagan AM; Morris JC; Ances BM
    Neurology; 2015 Mar; 84(12):1254-60. PubMed ID: 25716355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
    Mattsson-Carlgren N; Janelidze S; Palmqvist S; Cullen N; Svenningsson AL; Strandberg O; Mengel D; Walsh DM; Stomrud E; Dage JL; Hansson O
    Brain; 2020 Dec; 143(11):3234-3241. PubMed ID: 33068398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body Disease.
    Hall S; Janelidze S; Londos E; Leuzy A; Stomrud E; Dage JL; Hansson O
    Mov Disord; 2021 Mar; 36(3):767-771. PubMed ID: 33285015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts.
    Lantero-Rodriguez J; Vrillon A; Fernández-Lebrero A; Ortiz-Romero P; Snellman A; Montoliu-Gaya L; Brum WS; Cognat E; Dumurgier J; Puig-Pijoan A; Navalpotro-Gómez I; García-Escobar G; Karikari TK; Vanmechelen E; Ashton NJ; Zetterberg H; Suárez-Calvet M; Paquet C; Blennow K
    Alzheimers Res Ther; 2023 Mar; 15(1):48. PubMed ID: 36899441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.